Complex generics development services refer to specialized offerings provided by contract research organizations (CROs) and pharmaceutical companies for the research, development, and regulatory support of complex generic drugs. These services cater to the development of generic versions of intricate pharmaceutical products, such as modified-release formulations, inhalers, transdermal patches, and biosimilars.